Angiex Initiates Phase 1 Trial of Innovative AGX101 Cancer Therapy with Abzena's Support

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for...

August 09, 2024 | Friday | News
WestGene Biopharma Achieves Historic Dual IND Approvals for World's First mRNA Vaccine Targeting EBV-Related Cancers

WestGene Biopharma is proud to announce that its innovative mRNA therapeutic cancer vaccine, WGc-043, has received dual Investigational New Drug (IND) ap...

August 09, 2024 | Friday | News
Angiex Initiates Phase 1 Clinical Trial for AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Tumors

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for...

August 09, 2024 | Friday | News
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines

    NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria...

August 08, 2024 | Thursday | News
Thermo Fisher Scientific's SeCore™ CDx HLA A Sequencing System Receives FDA Clearance as Companion Diagnostic for Adaptimmune’s TECELRA® TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science,  announced that its SeCore™ CDx HLA A Sequencing System has been granted 5...

August 07, 2024 | Wednesday | News
Illumina Expands Oncology Testing with High-Throughput Assays for NovaSeq X Series

llumina a global leader in DNA sequencing and array-based technologies, today announced it has expanded its oncology menu for NovaSeq™ X Series custo...

August 06, 2024 | Tuesday | News
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovia...

August 05, 2024 | Monday | News
FDA Grants Accelerated Approval for TECELRA in Advanced Synovial Sarcoma Treatment

Approved for advanced MAGE-A4+synovial sarcoma in adults with certain HLA types who have received prior chemotherapy TECELRA is the first new treatment ...

August 02, 2024 | Friday | News
Bio-Rad Laboratories Announces Study on Rapid Bispecific Antibody Generation

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announced the publication of a peer-reviewed stud...

August 01, 2024 | Thursday | News
JelloX Biotech Collaborates with Mayo Clinic to Enhance 3D Digital Imaging for Precision Cancer Diagnosis

  JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Cli...

August 01, 2024 | Thursday | News
MSD Announces Positive CHMP Opinion for KEYTRUDA® and Padcev® Combo in Advanced Urothelial Carcinoma

MSD (NYSE: MRK), known as Merck & Co., Inc. in the United States and Canada, today announced that the European Medicines Agency’s Committee for...

July 29, 2024 | Monday | News
European Commission Approves AbbVie’s SKYRIZI® for Treatment of Moderately to Severely Active Ulcerative Colitis

AbbVie announced that the European Commission has approved SKYRIZI® (risankizumab) for the treatment of adult patients with moderately to severely ac...

July 29, 2024 | Monday | News
Kronos Bio Initiates Dosing of First Patient in Expansion Cohort with KB-0742 for High-Grade Serous Ovarian Cancer

Kronos Bio, a company dedicated to developing small molecule therapeutics that address cancers and other diseases driven by deregulated transcription, to...

July 24, 2024 | Wednesday | News
Bio-Rad Laboratories Announces Strategic Advances in Life Science and Clinical Diagnostics

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products,  provides an overview of advances supporting th...

July 24, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close